Outdoor pollen is a trigger of child and adolescent asthma emergency department presentations: A systematic review and meta-analysis
B Erbas, M Jazayeri, KA Lambert, CH Katelaris, LA Prendergast, R Tham, MJ Parrodi, J Davies, E Newbigin, MJ Abramson, SC Dharmage
ALLERGY | WILEY | Published : 2018
BACKGROUND: In the context of increased asthma exacerbations associated with climatic changes such as thunderstorm asthma, interest in establishing the link between pollen exposure and asthma hospital admissions has intensified. Here, we systematically reviewed and performed a meta-analysis of studies on pollen and emergency department (ED) attendance. METHODS: A search for studies with appropriate search strategy in MEDLINE, EMBASE, Web of Science and CINAHL was conducted. Each study was assessed for quality and risk of bias. The available evidence was summarized both qualitatively and meta-analysed using random-effects models when moderate heterogeneity was observed. RESULTS: Fourteen stud..View full abstract
Awarded by NHMRC AusPollen Partnership Project
Awarded by ARC Discovery
Michael Abramson holds investigator-initiated grants for unrelated research from Pfizer and Boehringer Ingelheim, and has received assistance with conference attendance from Sanofi. JMD receives current grant funding from the NHMRC AusPollen Partnership Project (GNT 1116107) with co-contributions from The Australasian Society for Clinical Immunology and Allergy, Asthma Australia, Bureau of Meteorology, Commonwealth Scientific and Industrial Research Organisation, Stallergenes Australia, Meteorology Switzerland, ARC Discovery (DP170101630), the Bureau of Meteorology on a Thunderstorm Asthma Pollen Forecasting Project, the National Foundation of Medical Research Innovation. She has received grants in the last 5 years from the NHMRC, National Foundation for Medical Research Innovation, the Allergy and Immunology Foundation of Australasia, Asthma Australia, Queensland University of Technology, The University of Queensland and a contracted research grant from Stallergenes (France), in-kind provision of materials from Thermo Fisher (Sweden) and services from Sullivan Nicolaides Pathology (QLD, Australia). She is an inventor on a patent assigned to QUT granted in Australia, allowed in USA and 3 applications pending examination in Australia, USA and Europe. JMD institute has received Honorarium payments and travel expenses for education sessions and conference presentations from Stallergenes Australia, GlaxoSmithKline, Wymedical and Meda Pharmaceuticals.